Dyne Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About DYN
All events for DYN
All deals for DYN
Financial Ratios
Financial Statements
DYN vs Sector & Peers
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts. Website dyne-tx.com
Headquarters Waltham, MA, US